Primary Care for HIV-Infected Patients in Resource-Limited Settings

  • Authors: Charles van der Horst, MD; F. Parker Hudson, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)

Summary

  • As part of the WHO recommendation that all persons diagnosed with HIV infection initiate ART regardless of WHO clinical stage or CD4+ cell count, all pregnant women should initiate lifelong triple-drug ART, even if diagnosed late in pregnancy or postpartum (Management Guidelines)[WHO ART]
    • Preferred first-line regimen in all pregnant and breastfeeding women—including those in the first trimester—is tenofovir, lamivudine (or emtricitabine), and efavirenz
    • If an efavirenz-based regimen cannot be used, a nevirapine-containing regimen may be used as an alternative but should be used with caution

Action required